Financial Times
UK · 3 hrs ago
Moderna shares double on skin cancer vaccine success
Drugmaker’s melanoma shot developed with Merck delivers positive outcome in late-stage trial
Do you trust Financial Times?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!